Company News
Clear Street Picks 5 Biotech Winners H2‑2026
Clear Street recommends five biotech stocks with Buy ratings and price targets ranging $18‑$116 for catalysts in H2 2026.
MoonLake Immunotherapeutics aims to raise ~$200 million via public offering an
